We are proud to announce our new SARS-CoV-2 Mutation Panel 1.0 to help researchersepidemiologists, and local, state, and federal health...

Biomeme has officially outgrown its home at 10th and Chestnut and is moving on to Netrality’s 401 North Broad Street for its new corporate...

As the world crosses the 1-year mark since the World Health Organization classified COVID-19 as a pandemic, testing is still as crucial as ever....

The Partnership

Back in May 2019, Biomeme and INDICAL Bioscience entered into an exclusive global licensing and research agreement in a joint...

We are thrilled to announce Biomeme, Inc. has been awarded a Redevelopment Assistance Capital Program (RACP) grant of $3 million from the...

Variant Country of Origin Biomeme Assay Detection
20I/501Y.V1 United Kingdom
20H/501Y.V2 South Africa
20J/501Y.V3 Brazil
...

The finalists have been announced and Biomeme is moving forward to the next round of XPRIZE Rapid COVID Testing, a $6 million dollar 6-month...

When you walk into Biomeme HQ in Philadelphia, you’ll find a bustling office overflowing with our staff, incoming and outgoing packages, and an...

Launched on July 28, 2020, XPRIZE Rapid Covid Testing is a $5 million, 6-month competition that aims to increase Covid-19 testing capabilities...